产品详情
Targets
Target | Value |
---|---|
VEGFR2/KDR | IC50: 37nM |
VEGFR1/FLT1 | IC50: 77nM |
VEGFR2/Flk1 | IC50: 270nM |
PDGFRβ | IC50: 580nM |
VEGFR3/FLT4 | IC50: 660nM |
c-Kit | IC50: 730nM |
c-Fms | IC50: 1.4μM |
In vitro | DMSO | 77 mg/mL (183.45 mM) | |
Water | 9 mg/mL (21.44 mM) | ||
Ethanol | 5 mg/mL (11.91 mM) | ||
* <1 mg/ml means slightly soluble or insoluble. * Please note that Adooq tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations. |
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
0.1 mM | 23.83 mL | 119.13 mL | 238.27 mL |
0.5 mM | 4.77 mL | 23.83 mL | 47.65 mL |
1 mM | 2.38 mL | 11.91 mL | 23.83 mL |
5 mM | 0.48 mL | 2.38 mL | 4.77 mL |
*The above data is based on the productmolecular weight 419.7 . Batch specific molecular weights may vary from batch to batch due to solvent of hydration, which will affect the solvent volumes required to prepare stock solutions.
目录号 | A10967 |
---|---|
作用机制 | Inhibitor (抑制剂) |
M. Wt | 419.7 |
Formula | C20H17Cl3N4 |
Purity | >99% |
Storage | Store lyophilized at -20ºC, keep desiccated. |
CAS No. | 212141-51-0 |
Synonyms | Vatalanib,PTK787,PTK/ZK |
SMILES | C1=CC=C2C(=C1)C(=NN=C2NC3=CC=C(C=C3)Cl)CC4=CC=NC=C4.Cl.Cl |
产品资料
产品标签
Product Questions
Product Questions
Brivanib (BMS-540215)
Brivanib (BMS-540215)是一种VEGFR-2抑制剂,IC50为25 nM,Ki为26 nM。
Pazopanib (GW-786034)
Pazopanib (GW-786034)是VEGFR-1,VEGFR-2,VEGFR-3,PDGFR-a/β和c-kit的有效且选择性的多靶点酪氨酸激酶抑制剂,可阻…
Imatinib (Gleevec)
Imatinib (Gleevec)是一种多靶点酪氨酸激酶抑制剂,抑制v-Abl、c-Kit和PDGFR的IC50分别为0.6,0.1和0.1 μM。
Telatinib (BAY 57-9352)
Telatinib (BAY 57-9352)是一种口服的血管内皮生长因子受体2和3(VEGFR2/3)和血小板衍生的生长因子受体β酪氨酸…
Bibf1120 (Nintedanib)
Bibf1120 (Nintedanib)是一种新型的三联血管激酶抑制剂,可同时抑制三种生长因子受体:VEGFR,PDGF和FGFR。